Search: onr:"swepub:oai:DiVA.org:oru-106325" >
Fosfomycin versus C...
-
Andreasson, A.Sahlgrenska university hospital, Dept. of Urology, Göteborg, Sweden
(author)
Fosfomycin versus Ciprofloxacin as transrectal prostatebiopsy antibiotic prophylaxis an open randomized controlled multicenter drug trial
- Article/chapterEnglish2023
Publisher, publication year, extent ...
-
Elsevier,2023
-
printrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:oru-106325
-
https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-106325URI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:vet swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
Introduction & Objectives: Antibiotic prophylaxis are administered as a routine to decrease the risk for septic complications following transrectal prostate biopsy. Fosfomycin administered 1 h or more prior to biopsy has equal or better infectious complication rates as compared to Ciprofloxacin in both prospective and retrospective studies from countries with high rates of antibiotic resistance. The aim of this study was to investigate if Fosfomycin administered immediately prior to prostate biopsy was as effective as Ciprofloxacin in Sweden, a country with low rates of antibiotic resistance.Materials & Methods: A randomized, controlled, open, multicenter, non-inferiority-study including men of all ages undergoing transrectal prostate biopsy was performed in the urology departments of three Swedish hospitals. The total number of patients were planned for 3448, divided into low and high infection risk groups. The low-risk group was randomized to either one dose of Fosfomycin 3g or Ciprofloxacin 750mg before biopsy. The high-risk group was randomized to either two doses of Fosfomycin 3g prior to biopsy and one more 24 h after biopsy or Ciprofloxacin 500mg once prior to biopsy and then twice daily for three days. The drugs were administered orally. All patients had a rectal swab for culture before and after biopsy. The endpoint was hospitalisation due to urinary tract infection within 14 days from biopsy, follow-up was performed with a phone interview.Results: The safety board prematurely interrupted the study after 42 included patients due to an unusual high number of hospitalisations. Four out of 20 patients (20%), three in the low-risk group and one in the high-risk group, had been hospitalised due to urosepsis in the Fosfomycin group. One further patient described fever symptoms but did not seek health care. No patient in the Ciprofloxacin group (n=21) described symptoms of infection from the urinary tract. One patient was lost to follow-up. A one-sided binomial test showed a p-value of <0.001. Two of the four hospitalised patients had a positive blood culture for Pseudomonas Aeruginosa and one had a positive rectal swab culture for Pseudomonas species both before and after biopsy.Conclusions: The study does not support the use of Fosfomycin administered immediately prior to prostate biopsy. The results may have been affected by the unexpected high number of Pseudomonas infections, a bacteria where Fosfomycin often lack effect. If Fosfomycin is to be used it should be with caution if Pseudomonas has been seen in earlier cultures
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Hällgren, A.Linköping university, Dept. of Biomedical and Clinical Sciences, Linköping, Sweden
(author)
-
Georgeoulas, P.Örebro University Hospital, Dept. of Urology, Örebro, Sweden
(author)
-
Forsberg, J.Linköping university, Dept. of Biomedical and Clinical Sciences, Linköping, Sweden
(author)
-
Fridriksson, J.Umeå University, Dept. of Surgical and Perioperative Sciences, Umeå, Sweden
(author)
-
Granåsen, G.Umeå University, Dept. of Public Health and Clinical Medicine, Umeå, Sweden
(author)
-
Lundström, K-JUmeå University, Dept. of Surgical and Perioperative Sciences, Umeå, Sweden
(author)
-
Resare, S.Norrland University Hospital, Dept. of Urology, Umeå, Sweden
(author)
-
Lönn, Backman B.Umeå University, Dept. of Nursing, Umeå, Sweden
(author)
-
Grabe, M.Lund university, Dept. of Translational Medicine, Lund, Sweden
(author)
-
Stattin, P.Uppsala university, Dept. of surgical sciences, Uppsala, Sweden
(author)
-
Stranne, J.Göteborg University, The Institute of Clinical Sciences, Göteborg, Sweden
(author)
-
Sundqvist, M.,1974-Örebro universitet,Institutionen för medicinska vetenskaper,Region Örebro län(Swepub:oru)mist
(author)
-
Styrke, J.Umeå University, Dept. of Surgical and Perioperative Sciences, Umeå, Sweden
(author)
-
Sahlgrenska university hospital, Dept. of Urology, Göteborg, SwedenLinköping university, Dept. of Biomedical and Clinical Sciences, Linköping, Sweden
(creator_code:org_t)
Related titles
-
In:European Urology: Elsevier83:Suppl. 1, s. S180-S1800302-28381873-7560
Internet link
Find in a library
To the university's database
- By the author/editor
-
Andreasson, A.
-
Hällgren, A.
-
Georgeoulas, P.
-
Forsberg, J.
-
Fridriksson, J.
-
Granåsen, G.
-
show more...
-
Lundström, K-J
-
Resare, S.
-
Lönn, Backman B.
-
Grabe, M.
-
Stattin, P.
-
Stranne, J.
-
Sundqvist, M., 1 ...
-
Styrke, J.
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Urology and Neph ...
- Articles in the publication
-
European Urology
- By the university
-
Örebro University